Comments by WHO Europe director, Hans Kluge
The EMA provided an update on Tuesday this week , reiterating what Kluge said above that „the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects“.
The EMA provided an update on Tuesday this week , reiterating what Kluge said above that „the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects“.